XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 34.50

+2.7%

Nov 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: StockDoc who wrote (14055)	7/11/2000 12:00:05 PM
From: aknahow	Read Replies (2) of 17367

Stockdoc, this is a link to Robert K's post which contains the link to the LLY patent filing. messages.clubs.yahoo.com We are now all aware that it is a filing for a patent, not an issued patent. No clinical trial of Protein C with BPI has been run but a trial protocol is described. While LLY's filing says Protein C works better when combined with BPI this is based on the alleged activity of the compounds, not on anything LLY has done on humans. LLY also indicates that Protein C may have adverse side effects which would be reduced through the combination. LLY says the same about BPI. <g> IMO we have classic case of smart company trying to stake out territory. The filing was done prior to the halt in the P III by DSMB for efficacy. The filing makes very interesting reading. LLY clearly is not ready to dismiss BPI and is interested in assuring its participation, IF, BPI eventually is approved for use.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next